Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:57 PM
Ignite Modification Date:
2025-12-24 @ 7:57 PM
NCT ID:
NCT02900404
Eligibility Criteria:
Inclusion Criteria:
* Female or male patient ≥18 years who provided signed and dated informed consent to the use of their medical data
* Patient was treated with rivaroxaban before and after surgery because of non-valvular atrial fibrillation (NVAF) or venous thromboembolism/pulmonary embolism (VTE/PE)
* Elective surgery in a department of General Surgery or Orthopedics / Trauma Surgery was performed within the last 12 months before study start
* The patient has been discharged from hospital
* Patient's medical records are available for data entry
Exclusion Criteria:
* Patient participated in an interventional drug study within 3 months prior to the surgery and discharge from hospital
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02900404
Study Brief:
Protocol Section:
NCT02900404